Literature DB >> 18936145

Spatial summation properties for magnocellular and parvocellular pathways in glaucoma.

Josephine Battista1, David R Badcock, Allison M McKendrick.   

Abstract

PURPOSE: To examine the spatial summation properties for the magnocellular (M) and parvocellular (P) visual pathways in participants with glaucoma and approximately age-matched controls in central and midperipheral retinal eccentricities.
METHODS: Contrast discrimination thresholds were measured for six different stimulus array sizes, using steady- and pulsed-pedestal paradigms designed to measure function of the M and P pathways, respectively. This study involved 15 participants with glaucoma and 17 approximately age-matched controls. All participants completed trials foveally and at 12.5 degrees eccentricity. The peripheral stimulus location for each glaucoma participant was within a quadrant of early visual field loss, and locations were matched for the control group.
RESULTS: The glaucoma group demonstrated significantly elevated thresholds compared with the control group (F((1,30)) = 16.29; P < 0.001). Thresholds were also significantly dependent on the stimulus sizes, testing location, and pedestal condition. Data obtained for the steady-pedestal paradigm were fit with an exponential decay function, whereas the pulsed-pedestal data were fit with a linear function, demonstrating different spatial summation properties for the M and P pathways, consistent with previous studies using this methodology. Analyses of the curve parameters obtained from the curve fits indicated no significant difference in the shape of the curves between glaucoma and control participants.
CONCLUSIONS: Although spatial summation properties are different for presumed M- and P-mediated pathways, the underlying spatial summation properties associated with these pathways are similar in the control and glaucoma participants in this study, centrally and midperipherally.

Entities:  

Mesh:

Year:  2008        PMID: 18936145     DOI: 10.1167/iovs.08-2517

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  The cell and molecular biology of glaucoma: mechanisms of retinal ganglion cell death.

Authors:  Robert W Nickells
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

2.  Functional loss in the magnocellular and parvocellular pathways in patients with optic neuritis.

Authors:  Dingcai Cao; Andrew J Zele; Joel Pokorny; David Y Lee; Leonard V Messner; Christopher Diehl; Susan Ksiazek
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-17       Impact factor: 4.799

3.  Linking structure and function in glaucoma.

Authors:  R S Harwerth; J L Wheat; M J Fredette; D R Anderson
Journal:  Prog Retin Eye Res       Date:  2010-03-11       Impact factor: 21.198

4.  Age-related changes in contrast gain related to the M and P pathways.

Authors:  Sarah L Elliott; John S Werner
Journal:  J Vis       Date:  2010-04-13       Impact factor: 2.240

5.  Sensory contributions to impaired emotion processing in schizophrenia.

Authors:  Pamela D Butler; Ilana Y Abeles; Nicole G Weiskopf; Arielle Tambini; Maria Jalbrzikowski; Michael E Legatt; Vance Zemon; James Loughead; Ruben C Gur; Daniel C Javitt
Journal:  Schizophr Bull       Date:  2009-09-30       Impact factor: 9.306

6.  Summation of Temporal L-Cone- and M-Cone-Contrast in the Magno- and Parvocellular Retino-Geniculate Systems in Glaucoma.

Authors:  Cord Huchzermeyer; Folkert Horn; Robert Lämmer; Christian Mardin; Jan Kremers
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-05-03       Impact factor: 4.799

7.  Effects of misalignments in the retinal nerve fiber layer thickness measurements with spectral domain optical coherence tomography.

Authors:  Kleyton A Barella; Fernanda Cremasco; Camila Zangalli; Vital P Costa
Journal:  J Ophthalmol       Date:  2014-12-09       Impact factor: 1.909

8.  Effects of glaucoma on detection and discrimination of image blur.

Authors:  Habiba A Bham; Jonathan Denniss
Journal:  Ophthalmic Physiol Opt       Date:  2022-01-24       Impact factor: 3.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.